Short Interest in Biofrontera Inc. (NASDAQ:BFRIW) Expands By 88.7%

by · The Markets Daily

Biofrontera Inc. (NASDAQ:BFRIW – Get Free Report) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 6,628 shares, an increase of 88.7% from the April 30th total of 3,513 shares. Based on an average daily volume of 13,984 shares, the days-to-cover ratio is presently 0.5 days.

Biofrontera Price Performance

Shares of Biofrontera stock opened at $0.02 on Tuesday. Biofrontera has a one year low of $0.02 and a one year high of $0.28. The stock’s fifty day moving average is $0.04 and its 200 day moving average is $0.05.

Biofrontera Company Profile

(Get Free Report)

Biofrontera AG is a biopharmaceutical company headquartered in Leverkusen, Germany, specializing in the development, manufacture and commercialization of dermatology products. Founded in 1997, the company focuses on therapies for skin diseases through innovative drug and device combinations. Its core business centers on photodynamic therapy, where a photosensitizing agent is activated by a specialized light source to treat precancerous and cancerous skin conditions.

The company’s flagship product, Ameluz, is a topical formulation of aminolevulinic acid used in conjunction with the BF-RhodoLED irradiation device.

Featured Stories